C4 Therapeutics Inc (CCCC) — Cash Flow Reinvestment Rate

Latest as of June 2019: 0.02x

C4 Therapeutics Inc (CCCC) has a Cash Flow Reinvestment Rate of 0.02x as of June 2019, reinvesting $641.00K (capex $641.00K ) from operating cash flow of $36.91 Million. Explore C4 Therapeutics Inc (CCCC) cash flow conversion to assess how effectively this company generates cash.

Reinvestment Rate

0.02x

(Capex + Investments) / Operating CF

Total Reinvested

$641.00K

Capex + Investments

Operating Cash Flow

$36.91 Million

USD

Capital Expenditures

$641.00K

USD

C4 Therapeutics Inc Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for C4 Therapeutics Inc across 1 annual periods. Explore investment intensity of C4 Therapeutics Inc to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for C4 Therapeutics Inc (2019–2019)

Year-by-year capital reinvestment analysis for C4 Therapeutics Inc. For live market cap and broader valuation context, see C4 Therapeutics Inc stock valuation.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2019	0.05x	$2.97 Million	$55.61 Million	$1.35 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow